摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

{Ru(bpy)2HAT}(2+) | 194738-35-7

中文名称
——
中文别名
——
英文名称
{Ru(bpy)2HAT}(2+)
英文别名
[Ru(2,2'-bipyridine)2(1,4,5,8,9,12-hexaazatriphenylene)](2+)
{Ru(bpy)2HAT}(2+)化学式
CAS
194738-35-7
化学式
C32H22N10Ru
mdl
——
分子量
647.664
InChiKey
FSSJFEGDZLMTSH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    六氟磷酸钾 、 [iridium(III)(μ-chloro)(2-phenylpyridine)2]2 、 {Ru(bpy)2HAT}(2+)甲醇二氯甲烷 为溶剂, 生成 [Ir(2-phenylpyridine)2(1,4,5,8,9,12-hexaazatriphenylene)Ru(2,2'-bipyridine)2](PF6)3
    参考文献:
    名称:
    New Charge Transfer Luminescent Polymetallic Complexes of Rhodium(III), Iridium(III), and Ruthenium(II) with the Bridging Ligand 1,4,5,8,9,12-Hexaazatriphenylene
    摘要:
    New emitting binuclear (Rh)(i)-(Ru)(2-i) (i = 1, 2), (Ir)-(Ru), and trinuclear (Rh)(i)-(Ru)(3-i) (i = 1, 2, 3) complexes assembled by the trischelating bridging ligand HAT (1,4,5,8,9,12-hexaazatriphenylene), have been synthesized. Their characterization by mass spectrometry (FAB and electrospray) is in accordance with their expected structure, where Rh(PPY)(2)(+) (or Ir(PPY)(2)(+)) and Ru(BPY)(2)(2+) correspond to the building blocks (PPY is the ortho-C-deprotonated form of 2-phenylpyridine and BPY is 2,2'-bipyridine). The HPLC data of these polymetallic compounds reveal that the trimetallic homo- and heteronuclear complexes are not stable under the chromatographic conditions and in some organic solvents. Therefore, the electrochemical and photophysical data are given only for the bimetallic compounds, stable under these conditions. Under electrochemical oxidation, the bimetallic Rh(III) complex shows one irreversible wave in the accessible potential range, while the heteronuclear Rh(III)-Ru(II) and Ir(III)-Ru(II) compounds exhibit an irreversible process followed by a reversible wave. For the bimetallic (homo- and heteronuclear) complexes, the first reduction wave involves a HAT-centered pi* orbital. On the basis of the electrochemical, luminescence and resonance Raman data, the lowest electronic transitions are CT (charge transfer) transitions involving the bridging HAT. These transitions have an MLCT (metal to ligand charge transfer) type for the Ru(II) moiety and a SBLCT (sigma-bond to ligand charge transfer) character for the Rh(III) unit; in the case of the Ir(III) moiety there is a strong admixture of SBLCT and MLCT character. An energy transfer would take place from the Ru-HAT (3)MLCT state towards the Ir-HAT (3)SBLCT (mixed with (3)MLCT character) in the Ir(III)-Ru(II) compound. For the Rh(III)-Ru(II) complex the nature of the luminescent excited state (Ru-HAT (3)MLCT or Rh-HAT (3)SBLCT) cannot be unambiguously determined.
    DOI:
    10.1021/ic00118a017
点击查看最新优质反应信息

同类化合物

舒立克隆 次黄嘌呤-[2,8-3H] 吡唑并[1,5-a]吡咯并[2,1-C]吡嗪 吡咯并[1,2-a]噻吩并[2,3-e]吡嗪 吡咯并[1,2-a]吡嗪-8-甲醛 吡咯并[1,2-a]吡嗪-6-甲醛(9CI) 吡咯并[1,2-a]吡嗪-3-羧酸乙酯 吡咯并[1,2-a]吡嗪-3-羧酸 吡咯并[1,2-a]吡嗪,4-乙基-(9CI) 吡咯并[1,2-a]吡嗪 吡咯并[1,2-A]吡嗪-6-甲醇 右佐匹克隆 佐匹克隆氧化物 佐匹克隆杂质3 佐匹克隆杂质1 佐匹克隆 二羰雙吡咯 乙酰氨基-6-吡咯并[1,2-a]噻吩并[2,3-e]吡嗪 乌帕替尼 乌帕替尼 N-甲基-5-溴-4,7-二氮杂吲哚 N-去甲基佐匹克隆 7-碘-5H-吡咯并[2,3-b]吡嗪 7-甲基-6,8-二(甲硫基)吡咯并[1,2-a]吡嗪 7-溴吡咯并[1,2-a]吡嗪-1(2H)-酮 7-氯甲基氧基-羰基氧基-6-(5-氯吡啶-2-基)-6,7-二氢-5H-吡咯并[3,4-b]吡嗪-5-酮 6-甲基-吡咯并[1,2-a]吡嗪 6-溴吡咯并[1,2-A]吡嗪-1(2H)-酮 6-溴吡咯[1,2-A]吡嗪-3-羧酸乙酯 6-(7-氯-1,8-萘啶-2-基)-6,7-二氢-7-羟基-5H-吡咯并[3,4-b]吡嗪-5-酮 6-(7-氯-1,8-萘啶-2-基)-2,3,6,7-四氢-7-羟基-5H-1,4-二噻英并[2,3-c]吡咯-5-酮 6-(5-氯-吡啶-2-基)-7-苯氧基羰基氧基-6,7-二氢-吡咯并3,4-b吡嗪-5-酮 6-(5-氯-2-吡啶基)-6,7-二氢-7-羟基-5H-吡咯并[3,4-b]吡嗪-5-酮 6-(5-氯-1,8-萘啶-2-基)-2,3,6,7-四氢-7-氧代-5H-1,4-二噻英并[2,3-c]吡咯-5-基4-甲基哌嗪-1-羧酸酯 6,7,8,9-四氢吡嗪并[1,2-A]吲哚-1(2H)-酮 5H-吡嗪并[2,3-b]吲哚 5H-吡咯并[2,3-b]吡嗪-7-羧醛 5H-吡咯并[2,3-b]吡嗪-2-羧酸甲酯 5H-吡咯[2,3-B]吡嗪-7-乙酸 5-甲基-5H-吡咯并[2,3-b]吡嗪-7-羧酸甲酯 5-溴-4,7-二氮杂吲哚 5-氯-2-(7-氯-1,8-萘啶-2-基)-3-羟基异吲哚啉-1-酮 5-氢吡咯并[2,3-b]吡嗪-7-甲酸 4,7-二氮杂吲哚 3-羟基-2-(7-甲氧基-[1,8]萘啶-2-基)-2,3-二氢-异吲哚-1-酮 3-甲基吡咯并[1,2-a]吡嗪-1(2H)-酮 3-溴-5H-吡咯并[2,3-b]吡嗪 3-溴-4,7-二氮杂吲哚 3-氯-5H-吡咯并[2,3-b]吡嗪 3,6,7-三甲基吡咯并[1,2-a]吡嗪